Literature DB >> 22154920

Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery.

Liselotte Ruts1, Pieter A van Doorn, Raffaella Lombardi, Elize D Haasdijk, Paola Penza, Joke H M Tulen, Roelie J Hempel, Anton H van den Meiracker, Giuseppe Lauria.   

Abstract

We performed a prospective study in 32 patients with Guillain-Barré syndrome (GBS) or its variants to correlate intraepidermal nerve fiber density (IENFD) at the distal leg and lumbar region with pain, autonomic dysfunction, and outcome. In the acute phase, IENFD was reduced in 60% and 61.9% of patients at the distal leg and lumbar region, respectively. In the acute phase, 43.7% of patients complained of neuropathic pain. Their IENFD at the distal leg was significantly lower than in patients without pain (P<.001) and correlated with pain intensity (r(s)=-0.51; P=.003). Intriguingly, also patients with the pure motor variant of GBS and pain had low IENFD. At 6-month follow-up, only 3 patients complained of persisting neuropathic pain, whereas 3 patients reported late-onset pain symptoms. IENFD in the acute phase did not predict presence or intensity of pain at 6-month follow-up. IENFD in the acute phase did not correlate with clinical dysautonomia or GBS severity at nadir. However, it correlated with poorer GBS disability score at 6 months (P=.04), GBS score at nadir (P=.03), and clinically probable dysautonomia (P=.004). At 6-month follow-up, median IENFD remained significantly low both at the distal leg (P=.024) and lumbar region (P=.005). Double and triple staining confocal microscope studies showed diffuse damage of myelinated dermal nerves along with axonal degeneration, and mononuclear cell infiltration. Unmyelinated and myelinated skin nerves are diffusely affected in GBS and its variants, including the pure motor form. IENFD declines early, remains low over time, correlates with pain severity in the acute phase, and may predict long-term disability.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22154920     DOI: 10.1016/j.pain.2011.10.037

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

Review 1.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

2.  [Guillain-Barre syndrome complicated on post-operation with renal carcinoma and meningioma: a case report].

Authors:  S Xu; Y S Wang; S Li; H Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 3.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 4.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

5.  Small nerve fiber involvement in CMT1A.

Authors:  Maria Nolano; Fiore Manganelli; Vincenzo Provitera; Chiara Pisciotta; Annamaria Stancanelli; Giuseppe Caporaso; Rosa Iodice; Michael E Shy; Lucio Santoro
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

Review 6.  Headache and Pain in Guillain-Barré Syndrome.

Authors:  Constantine Farmakidis; Seniha Inan; Mark Milstein; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2015-08

7.  The relationship of nerve fibre pathology to sensory function in entrapment neuropathy.

Authors:  Annina B Schmid; Jeremy D P Bland; Manzoor A Bhat; David L H Bennett
Journal:  Brain       Date:  2014-10-27       Impact factor: 13.501

8.  Neuropathic pain in animal models of nervous system autoimmune diseases.

Authors:  David H Tian; Chamini J Perera; Gila Moalem-Taylor
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

9.  What is the meaning of "small-fiber polyneuropathy" in fibromyalgia? An alternate answer.

Authors:  Anne Louise Oaklander
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

10.  Small nerve fiber pathology in critical illness.

Authors:  Nicola Latronico; Massimiliano Filosto; Nazzareno Fagoni; Laura Gheza; Bruno Guarneri; Alice Todeschini; Raffaella Lombardi; Alessandro Padovani; Giuseppe Lauria
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.